Determine the Effect of Multiple Doses of AZD7325, CYP Study

NCT00790114 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: AZD7325
DRUG: Midazolam
DRUG: Caffeine

Sponsor

AstraZeneca